Development of Parvovirus H-1 as an oncolytic therapeutic for the treatment of malignant gliomas: from initial discovery to clinical application

Ähnliche Einträge

• Oncolytic parvoviruses as cancer therapeutics
  von: Rommelaere, Jean, et al.
  Veröffentlicht: (2010)
• Immunotherapeutic potential of oncolytic H-1 parvovirus: hints of glioblastoma microenvironment conversion towards immunogenicity
  von: Angelova, Assia L., et al.
  Veröffentlicht: (2017)
• Regression of advanced rat and human gliomas by local or systemic treatment with oncolytic parvovirus H-1 in rat models
  von: Geletneky, Karsten, et al.
  Veröffentlicht: (2010)
• Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection
  von: Geletneky, Karsten, et al.
  Veröffentlicht: (2010)
• Tumor selectivity of oncolytic parvoviruses: from in vitro and animal models to cancer patients
  von: Angelova, Assia L., et al.
  Veröffentlicht: (2015)